Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

DaVita HealthCare Partner (NY: DVA )

141.59 +1.78 (+1.27%)
Official Closing Price Updated: 7:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DaVita HealthCare Partner

< Previous 1 2 3 4 5 6 7 Next >
DaVita Inc. (NYSE: DVA) Climbs to New 52-Week High
Via Investor Brand Network
Wall Street Is Cautious on These 2 First Half Winners
There have been many stock winners in 2023 so far, but Wall Street is feeling cautious on these two first half outperformers. 
Via MarketBeat
Topics Economy
Exposures Economy Interest Rates
The 7 Most Undervalued Buffett Stocks to Buy Now: June 2023
Follow the lead of the 'Oracle of Omaha' with these seven undervalued Buffett stocks held in the Berkshire Portfolio. 
Via InvestorPlace
Why Nuwellis Shares Are Trading Higher Today
Nuwellis, Inc. (NASDAQ: NUWE) shares are trading high after the company entered a supply and  
Via Benzinga
Looking Into DaVita's Return On Invested Capital
Via Benzinga
DaVita Stock Sees Rising Relative Strength
On Wednesday, DaVita stock cleared a key technical benchmark, seeing its Relative Strength (RS) Rating jump to 91, up from 78 the day before. 
Via Investor's Business Daily
The Latest Analyst Ratings for DaVita
Via Benzinga
DaVita Inc. (NYSE: DVA) Making Surprising Moves in Tuesday Session
Via Investor Brand Network
Why Shares of DaVita Were Up Tuesday
The dialysis company's raised guidance encouraged investors. 
Via The Motley Fool
Why Buffett Loves These 3 Stocks
An interviewer once asked Warren Buffett about the worst trade he’d ever made… and he didn’t hesitate to answer… Buying Berkshire Hathaway. 
Via Benzinga
These 2 Stocks Are Popping -- and It Could Be Just the Beginning
Even in a down market, these companies stood out. 
Via The Motley Fool
Why PRA Group Shares Are Trading Lower By 44%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers TScan Therapeutics, Inc. (NASDAQ: TCRX) shares gained 118% to $4.68 after the company and Amgen announced collaboration to identify novel targets in Crohn's disease. 
Via Benzinga
DaVita (DVA) Q1 2023 Earnings Call Transcript
DVA earnings call for the period ending March 31, 2023. 
Via The Motley Fool
DaVita (DVA) Q4 2022 Earnings Call Transcript
DVA earnings call for the period ending December 31, 2022. 
Via The Motley Fool
VIX Rallies Amid Quiet Day On Wall Street
Wall Street is relatively quiet today, as investors continue to await this week's inflation data. 
Via Talk Markets
McKesson, ICU Medical, Novavax And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded lower, with the Dow Jones dropping around 50 points on Tuesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Warren Buffett Owns More Than a 23% Stake in These 3 Stocks
Many institutional investors don't like to purchase more than a 10% stake in a company. 
Via The Motley Fool
3 Medical Device Stocks to Buy for Cutting-Edge Innovation and Growth
Medical device stocks are set to rise with an aging population and continued improvements in technology. Here are 3 stocks to watch. 
Via InvestorPlace
Here's How Much You Would Have Made Owning DaVita Stock In The Last 20 Years
Via Benzinga
Here's How Much $1000 Invested In DaVita 20 Years Ago Would Be Worth Today
Via Benzinga
If You Invested $100 In This Stock 20 Years Ago, You Would Have $900 Today
Via Benzinga
$1000 Invested In This Stock 20 Years Ago Would Be Worth $8,500 Today
Via Benzinga
You Won't Believe How Much More Warren Buffett Has Made Than the Market Since 1965
The trick is waiting long enough to let the magic of compounding do its work. 
Via The Motley Fool
The 7 Best Beaten-Down Warren Buffett Stocks to Buy
Investors will want to take a close look at these beaten-down Warren Buffett stocks to buy for long-term appreciation. 
Via InvestorPlace
Stryker, DaVita And These 2 ETFs: CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Liz Young of BNY Mellon Investment Management named the  SPDR S&P Biotech ETF (NYSE: XBI), saying if you "want growth, 
Via Benzinga
Sell These 3 Stocks and Kick These Overpaid CEOs Out of Your Portfolio
Now is the time to cut your losses on some of your 2022 losers. Here are three stocks to sell whose CEOs didn’t earn their keep. 
Via InvestorPlace
Siemens Healthineers, GE Healthcare Studying Potential Deals With Medtronic's Spun Off Units
Via Benzinga
Warren Buffett Now Owns 20% or More of These 5 Companies
Which are these big Buffett bets are the best picks for investors? 
Via The Motley Fool
$1000 Invested In DaVita 20 Years Ago Would Be Worth This Much Today
DaVita (NYSE:DVA) has outperformed the market over the past 20 years by 3.82% on an annualized basis producing an average annual return of 11.29%. Currently, DaVita has a market capitalization of $6.29... 
Via Benzinga
DaVita Earnings Perspective: Return On Capital Employed
Pulled from Benzinga Pro data, DaVita (NYSE:DVA) showed a loss in earnings since Q2, totaling $164.69 million. Sales, on the other hand, increased by 0.75% to $2.95 billion during Q3. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.